Compare CDMOs with lyophilization capabilities for biologics, peptides, and injectable products. Filter by dryer capacity, cycle development expertise, and scale.
186 companies listed
China
Guangzhou RiboBio Co., Ltd. operates a CDMO/CMO platform (RiboPharm) that is Asia's largest GMP oligonucleotide API manufacturer, with over 20,000 sqm of planned production area. The company provides comprehensive oligonucleotide drug discovery, process and analytical development, CMC services, API production, and aseptic fill-finish, serving global pharmaceutical companies in bringing nucleic acid drugs from development to market.
China
Shenzhen Hybio Pharmaceutical Co., Ltd. (Hybio) is a Chinese pharmaceutical company founded in 1998, specializing in peptide drug R&D, manufacturing, and commercialization with a CRDMO division. The company focuses on peptide APIs (including semaglutide) and sterile injectable formulations, with products sold in 30+ countries. Hybio has 7 FDA-registered facilities and a strategic partnership with Dr. Reddy's for peptide API supply, and recently partnered with Huawei for AI-driven drug development.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.